These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10939898)

  • 1. High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer.
    Tempfer C; Seifert M
    N Engl J Med; 2000 Aug; 343(6):439; author reply 440-1. PubMed ID: 10939898
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer.
    Brodowicz T; Auerbach L; Zielinski C
    N Engl J Med; 2000 Aug; 343(6):439-40; author reply 440-1. PubMed ID: 10939899
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer.
    Iacopino P; Palazzo S; Patrone F
    N Engl J Med; 2000 Aug; 343(6):440; author reply 440-1. PubMed ID: 10939900
    [No Abstract]   [Full Text] [Related]  

  • 4. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group.
    Stadtmauer EA; O'Neill A; Goldstein LJ; Crilley PA; Mangan KF; Ingle JN; Brodsky I; Martino S; Lazarus HM; Erban JK; Sickles C; Glick JH
    N Engl J Med; 2000 Apr; 342(15):1069-76. PubMed ID: 10760307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer.
    Lippman ME
    N Engl J Med; 2000 Apr; 342(15):1119-20. PubMed ID: 10760313
    [No Abstract]   [Full Text] [Related]  

  • 6. Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer.
    Tallman MS; Gray R; Robert NJ; LeMaistre CF; Osborne CK; Vaughan WP; Gradishar WJ; Pisansky TM; Fetting J; Paietta E; Lazarus HM
    N Engl J Med; 2003 Jul; 349(1):17-26. PubMed ID: 12840088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide/carboplatin/etoposide chemotherapy for metastatic breast cancer with or without autologous hematopoietic stem cell transplantation: evaluation of dose-response relationships.
    Perkins JB; Fields KK; Elfenbein GJ
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):5-8. PubMed ID: 7610398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose intensification and breast cancer.
    Khayat D; Antoine E
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():153-77. PubMed ID: 9210898
    [No Abstract]   [Full Text] [Related]  

  • 9. [CBDCA, etoposide and epirubicin high-dose combination chemotherapy supported by peripheral blood stem cell transplantation (PBSCT) in metastatic breast cancer].
    Suwata J; Takada S; Murata N; Ishizuka N; Idezuki Y; Kobayashi M
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):83-8. PubMed ID: 9987502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.
    Rodenhuis S; Bontenbal M; Beex LV; Wagstaff J; Richel DJ; Nooij MA; Voest EE; Hupperets P; van Tinteren H; Peterse HL; TenVergert EM; de Vries EG;
    N Engl J Med; 2003 Jul; 349(1):7-16. PubMed ID: 12840087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High-dose chemotherapy with four drugs and peripheral blood progenitor cell autologous transplantation in disseminated breast cancer].
    Martín M; Casado A; Llorente L; López Martín JA; Rodríguez Lescure A; Nieto Y; Ayala F; Pérez Calvo J; Alonso JL; Pérez López C; Villegas A; Díaz-Rubio E
    Med Clin (Barc); 1997 Dec; 109(20):775-81. PubMed ID: 9493155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High-dose chemotherapy with hematopoietic stem-cell support in breast cancer].
    Viens P; Maraninchi D
    Bull Cancer; 2001 Sep; 88(9):835-41. PubMed ID: 11604355
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival and engraftment.
    Klumpp TR; Goldberg SL; Magdalinski AJ; Mangan KF
    Bone Marrow Transplant; 1997 Aug; 20(4):273-81. PubMed ID: 9285541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience.
    Laport GF; Grad G; Grinblatt DL; Bitran JD; Williams SF
    Bone Marrow Transplant; 1998 Jan; 21(2):127-32. PubMed ID: 9489628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer.
    Rizzo JD; Williams S; Wu JT; Pecora AL; Lazarus HM; Bolwell B; Fields KK; Gale RP; Elfenbein G; Horowitz MM; Antman KH
    Bone Marrow Transplant; 2003 Jul; 32(2):151-5. PubMed ID: 12838279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
    Shi Y; Pan F; Han X
    Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study.
    Toh HC; McAfee SL; Sackstein R; Multani P; Cox BF; Garcia-Carbonero R; Colby C; Spitzer TR
    Bone Marrow Transplant; 2000 Jan; 25(1):19-24. PubMed ID: 10654009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose cyclophosphamide, thiotepa and hydroxyurea with autologous hematopoietic stem cell rescue: an effective consolidation chemotherapy regimen for early metastatic breast cancer.
    Vaughan WP; Reed EC; Edwards B; Kessinger A
    Bone Marrow Transplant; 1994 May; 13(5):619-24. PubMed ID: 7914447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer.
    Bilgrami S; Feingold JM; Bona RD; Edwards RL; Khan AM; Rodriguez-Pinero F; Khan IA; Kazierad D; Clive J; Tutschka PJ
    Bone Marrow Transplant; 2000 Jan; 25(2):123-30. PubMed ID: 10673668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose therapy for the treatment of breast cancer: evaluation of effect of regimen on outcome.
    Fields KK; Perkins JB; Partyka JS; Elfenbein GJ
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S30-3. PubMed ID: 8899167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.